LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.03 | 17.25 | 663 | 5367 | 0.1235 | 0.5537 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.03 | 17.25 | 4 | 5367 | 0.0007 | -0.1618 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.03 | 17.25 | 761 | 5367 | 0.1418 | 0.5798 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.00 | 17.25 | 1 | 5546 | 0.0002 | -0.2896 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.00 | 17.25 | 630 | 5546 | 0.1136 | 0.5403 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.00 | 17.25 | 1 | 5546 | 0.0002 | -0.2896 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.00 | 17.25 | 766 | 5546 | 0.1381 | 0.5769 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.97 | 17.25 | 1 | 5618 | 0.0002 | -0.2891 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.97 | 17.25 | 631 | 5618 | 0.1123 | 0.5391 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.97 | 17.25 | 1 | 5618 | 0.0002 | -0.2891 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.97 | 17.25 | 764 | 5618 | 0.1360 | 0.5748 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.94 | 17.25 | 1 | 5681 | 0.0002 | -0.2886 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.94 | 17.25 | 592 | 5681 | 0.1042 | 0.5261 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.94 | 17.25 | 1 | 5681 | 0.0002 | -0.2886 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.94 | 17.25 | 743 | 5681 | 0.1308 | 0.5682 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.91 | 17.25 | 1 | 5730 | 0.0002 | -0.2882 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.91 | 17.25 | 502 | 5730 | 0.0876 | 0.4955 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.91 | 17.25 | 1 | 5730 | 0.0002 | -0.2882 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.91 | 17.25 | 719 | 5730 | 0.1255 | 0.5610 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.88 | 17.25 | 1 | 5826 | 0.0002 | -0.2876 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.88 | 17.25 | 429 | 5826 | 0.0736 | 0.4661 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.88 | 17.25 | 1 | 5826 | 0.0002 | -0.2876 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.88 | 17.25 | 708 | 5826 | 0.1215 | 0.5562 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.85 | 17.25 | 1 | 5861 | 0.0002 | -0.2873 | MN20160310_N02 | F05 |